Tunable CAR-NK-92 activity in the tumor microenvironment via a dual ATF4-responsive circuit
Chimeric antigen receptor–engineered NK-92 (CAR-NK-92) cells emulate activated natural killer cells, combining potent innate cytotoxicity with CAR-driven antigen specificity. Their scalability and FDA approval make them attractive for universal use. Ho…